New England Capital Financial Advisors LLC

Position in MRK — Merck & Co., Inc.

CIK 1964652 MERIDEN, CT

Position in MRK

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$281,800

+$19,328 QoQ

Shares Held

2,193

+0.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.92%

of 13F equity value

Holder Rank

#1,384

of 1,644 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

New England Capital Financial Advisors LLC holds $1,698,786 across 11 Drug Manufacturers - General names. MRK ranks #2 (16.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	2,860	$726,354
2	MRK	Merck & Co., Inc. This page	2,193	$281,800
3	BMY	Bristol Myers Squibb Co	4,319	$248,860
4	PFE	Pfizer Inc	5,713	$137,569
5	AZN	Astrazeneca PLC	560	$106,187
6	ABBV	AbbVie Inc.	363	$91,345
7	GILD	Gilead Sciences, Inc.	390	$49,272
8	LLY	ELI LILLY & Co	34	$40,780

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$281,800	2,193	+0.5%	Shares	Sole	2026-07-27
2026-03-31	$262,472	2,182	+0.6%	Shares	Sole	2026-04-27
2025-12-31	$228,414	2,170	+0.6%	Shares	Sole	2026-02-02
2025-09-30	$180,953	2,156	-3.8%	Shares	Sole	2025-10-22
2025-06-30	$177,318	2,240	+0.6%	Shares	Sole	2025-08-08
2025-03-31	$199,805	2,226	-7.4%	Shares	Sole	2025-05-05
2024-12-31	$239,249	2,405	+0.7%	Shares	Sole	2025-02-04
2024-09-30	$271,294	2,389	+0.6%	Shares	Sole	2024-10-30
2024-06-30	$294,025	2,375	+0.6%	Shares	Sole	2024-07-29
2024-03-31	$311,533	2,361	+0.6%	Shares	Sole	2024-05-02
2023-12-31	$255,869	2,347	+0.7%	Shares	Sole	2024-02-01
2023-09-30	$239,976	2,331	+0.6%	Shares	Sole	2023-11-06
2023-06-30	$267,358	2,317	-4.1%	Shares	Sole	2023-08-02
2023-03-31	$257,038	2,416	-7.2%	Shares	Sole	2023-05-04
2022-12-31	$288,913	2,604	—	Shares	Sole	2023-02-06
No filing history on record for this holder in this stock.